Industry Trend Analysis - Long-Term Picture Bright Yet Challenges Remain Firm - SEPT 2017

BMI View : Egypt ' s pharmaceutical market has significant growth potential, supported by a promising manufacturing base and the government ' s commitment to advancing its investment status in the region. Increasing political will from the Egyptian government to develop the pharmaceutical sector will bode well for the market ' s long-term attractiveness; however , currency issues and an uncertain economic future compound an increasingly difficult investment opportunity for multinational firms.

Egypt's pharmaceutical market will remain among the largest in the Middle East and North Africa (MENA) region, which, combined with a number of inherent advantages, makes its long-term growth story compelling. These include: a strategic geographical position for foreign investment, a well-established manufacturing industry for pharmaceuticals and notable government commitment to sector development. Over the near term, the impact of high inflation and negative currency effects will create a more precarious state for Egypt's pharmaceutical market attractiveness to investors.

Robust Growth Drivers

Driving Factors Underpin A Favourable Outlook
Egypt: Pharmaceutical Market Forecast
f = BMI forecast. Source: UN Comtrade, National Sources, BMI

This article is part of our Middle East & Africa coverage. To access this article subscribe now or sign up for free trial